Home › Compare › KONEF vs FCPT

KONEF vs FCPT: Dividend Comparison 2026

KONEF yields 20000000.00% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KONEF wins by $4.875981653489057e+49M in total portfolio value
10 years
KONEF
KONEF
● Live price
20000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.875981653489057e+49M
Annual income
$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00
Full KONEF calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — KONEF vs FCPT

📍 KONEF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKONEFFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KONEF + FCPT cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
KONEF pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KONEF
Annual income on $10K today (after 15% tax)
$1,700,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$41,445,436,407,424,570,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, KONEF beats the other by $41,445,436,407,424,570,000,000,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KONEF + FCPT for your $10,000?

KONEF: 50%FCPT: 50%
100% FCPT50/50100% KONEF
Portfolio after 10yr
$2.4379908267445285e+49M
Annual income
$24,379,668,474,955,630,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
100.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

KONEF
No analyst data
Altman Z
-9.9
Piotroski
2/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KONEF buys
0
FCPT buys
0
No recent congressional trades found for KONEF or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKONEFFCPT
Forward yield20000000.00% ✓6.05%
Annual dividend / share$2.00 ✓$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$4.875981653489057e+49M$49.1K ✓
Annual income after 10y$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00 ✓$5,775.28
Total dividends collected$4.875978515990276e+49M$24.1K ✓
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: KONEF vs FCPT ($10,000, DRIP)

YearKONEF PortfolioKONEF Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$2,000,010,700$2,000,000,000.00$11,401$700.92+$2000.00M → KONEF
2$373,835,915,712,384$373,833,775,700,934.50$13,064$864.84+$373835915.70M → KONEF
3$65,304,953,364,964,970,000$65,304,553,360,535,160,000.00$15,051$1,072.48+$65304953364964.95M → KONEF
4$10,661,728,832,755,500,000,000,000$10,661,658,956,455,399,000,000,000.00$17,442$1,337.22+$10661728832755499008.00M → KONEF
5$1,626,767,783,781,495,000,000,000,000,000$1,626,756,375,731,643,800,000,000,000,000.00$20,340$1,677.08+$1.626767783781495e+24M → KONEF
6$231,974,330,054,625,100,000,000,000,000,000,000$231,972,589,413,096,470,000,000,000,000,000,000.00$23,880$2,116.57+$2.319743300546251e+29M → KONEF
7$30,915,106,403,922,057,000,000,000,000,000,000,000,000$30,914,858,191,388,900,000,000,000,000,000,000,000,000.00$28,241$2,689.36+$3.0915106403922057e+34M → KONEF
8$3,850,507,985,839,278,000,000,000,000,000,000,000,000,000,000$3,850,474,906,675,425,000,000,000,000,000,000,000,000,000,000.00$33,660$3,442.07+$3.8505079858392777e+39M → KONEF
9$448,210,261,035,314,200,000,000,000,000,000,000,000,000,000,000,000$448,206,140,991,769,400,000,000,000,000,000,000,000,000,000,000,000.00$40,456$4,439.95+$4.4821026103531426e+44M → KONEF
10$48,759,816,534,890,570,000,000,000,000,000,000,000,000,000,000,000,000,000$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00$49,063$5,775.28+$4.875981653489057e+49M → KONEF

KONEF vs FCPT: Complete Analysis 2026

KONEF — Stock

KetamineOne Capital Limited, a next generation wellness company, focuses on ketamine assisted therapy and psychedelic medicines through operating healthcare clinics in North America. The company was formerly known as Myconic Capital Corp. and changed its name to KetamineOne Capital Limited in June 2021. KetamineOne Capital Limited was founded in 2017 and is headquartered in Vancouver, Canada.

Full KONEF Calculator →

FCPT — REIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this KONEF vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KONEF vs SCHDKONEF vs JEPIKONEF vs OKONEF vs KOKONEF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.